Management of Endometriosis with Oxidative Stress and Fertility Concerns

Introduction to Endometriosis Management

The American College of Obstetricians and Gynecologists recommends that for women of reproductive age with endometriosis who desire to preserve fertility, medical hormonal treatment does not improve future fertility outcomes and should be avoided in those actively seeking pregnancy; instead, surgical excision by a specialist is the definitive treatment, followed by assisted reproduction techniques if necessary 1

The European Society of Human Reproduction and Embryology suggests performing diagnostic laparoscopy with complete surgical excision of all visible endometriotic lesions by an endometriosis specialist 1
The American Society for Reproductive Medicine recommends completing multiple classifications during surgery: r-ASRM for general staging, Enzian if deep endometriosis is present, and the Endometriosis Fertility Index (EFI) to predict fertility outcomes 2
The Endometriosis Fertility Index (EFI) is a simple, robust, and validated clinical tool that predicts fertility outcome for women after surgical staging of endometriosis and has considerable utility in developing treatment plans 2

The American College of Obstetricians and Gynecologists advises against using hormonal suppression (oral contraceptives, progestins, GnRH agonists) in women actively seeking pregnancy, as medical treatment does not improve future fertility outcomes 1
The European Society of Human Reproduction and Embryology recommends proceeding directly to assisted reproduction techniques if spontaneous pregnancy does not occur within 6 months post-surgery, especially since up to 44% of women experience symptom recurrence within a year after surgery 3, 1

The American College of Obstetricians and Gynecologists suggests initiating treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen 550 mg twice daily or ibuprofen 600-800 mg three times daily for immediate pain relief 3, 4
The American College of Obstetricians and Gynecologists recommends that combined oral contraceptives provide effective pain relief compared to placebo and may be equivalent to more expensive regimens, with a superior safety profile 3, 1
The European Society of Human Reproduction and Embryology advises that progestins (oral or depot medroxyprogesterone acetate) are effective alternatives with similar efficacy to other hormonal treatments 3, 1

The American College of Obstetricians and Gynecologists states that surgery provides significant pain reduction during the first 6 months after the procedure, but it should be considered that up to 44% of women experience symptom recurrence within a year 3, 1, 4
The European Society of Human Reproduction and Embryology recommends that for severe endometriosis, medical treatment alone may not be sufficient, and surgical intervention should be considered when medical treatment is ineffective or contraindicated 3, 1

The American College of Obstetricians and Gynecologists notes that no medical therapy completely eradicates endometriotic lesions; hormonal treatments only temporize symptoms but cannot eradicate the disease 1, 4
The European Society of Human Reproduction and Embryology advises that the severity of pain correlates poorly with laparoscopic appearance but correlates with the depth of lesions, not with the type of lesions seen 1, 4
The American College of Obstetricians and Gynecologists recommends that high-quality preoperative imaging with pelvic MRI reduces morbidity and mortality by decreasing incomplete surgeries and the need for repeat procedures 1
The American College of Obstetricians and Gynecologists states that hormone replacement therapy with estrogen is not contraindicated after hysterectomy and bilateral salpingo-oophorectomy for endometriosis 3, 1, 4